Company Filing History:
3 out of 10 
2 out of 2,405 
1 out of 1,327 
Years Active: 2017-2025
Title: H Marie Loughran: Innovator in Neurodegenerative Disease Treatment
Introduction
H Marie Loughran is a distinguished inventor based in Perkasie, PA, with an impressive portfolio boasting seven patents. Her groundbreaking work primarily focuses on developing compounds that inhibit the formation of tau oligomers, which are closely linked to neurodegenerative diseases.
Latest Patents
Loughran's most recent patents include novel benzofuran, benzothiophene, and indole analogs that serve as inhibitors of tau oligomer formation. These compounds are particularly useful in the treatment of neurodegenerative diseases and related conditions. The patent details not only the compounds themselves but also their pharmaceutically acceptable salts, processes for their preparation, intermediates used in their synthesis, and relevant pharmaceutical compositions. Additionally, she holds a patent for quinazolinones that similarly inhibit tau oligomer formation, reinforcing her commitment to addressing the challenges posed by neurodegenerative diseases.
Career Highlights
Throughout her career, Loughran has made significant contributions to the field of pharmaceutical research, particularly in the development of therapeutic agents targeting neurodegenerative conditions. Her work is well-respected in the industry, highlighted by her successful patents that demonstrate her innovative approach to drug development.
Collaborations
Loughran has collaborated with esteemed colleagues such as Allen B. Reitz and Eliot J. Davidowitz, further enhancing her contributions to the field. She has also been associated with notable companies such as Oligomerix, Inc. and Merck Sharp & Dohme Corporation, where her expertise has played a key role in advancing research and development efforts.
Conclusion
H Marie Loughran stands out as an influential inventor in the realm of neurodegenerative disease treatment. Her patented innovations reflect her dedication to improving healthcare outcomes and her ongoing efforts to combat challenging diseases. Through her career, she has solidified her position as a leader in pharmaceutical innovation, paving the way for future advancements in the treatment of neurodegenerative disorders.